Clinical predictors of successful magnetic resonance-guided focused ultrasound (MRgFUS) for uterine leiomyoma

BACKGROUND: Magnetic resonance-guided focused ultrasound (MRgFUS) is a relatively new minimally invasive treatment, approved by the US Food and Drug Administration in 2004 for treatments of symptomatic uterine leiomyomas (fibroids). The purpose of this work is to present retrospective cohort analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorny, Krzysztof R, Borah, Bijan J, Weaver, Amy L, Brown, Douglas, Woodrum, David A, Stewart, Elizabeth A, Hesley, Gina K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265948/
https://www.ncbi.nlm.nih.gov/pubmed/25512860
http://dx.doi.org/10.1186/2050-5736-1-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265948/
https://www.ncbi.nlm.nih.gov/pubmed/25512860
http://dx.doi.org/10.1186/2050-5736-1-15

Ejemplares similares